For the most up to date information on COVID-19 please visit the Department of Health website. Learn more about how the AIHW is assisting the COVID-19 response and how our other work is affected. Our Covid-19 related resources page includes a list of some existing resources which may be useful when researching issues related to COVID-19.
Arthritis and other musculoskeletal conditions are Australia's fourth most expensive group of diseases, according to a report released today by the Australian Institute of Health and Welfare (AIHW).
The report, Health-care expenditure for arthritis and other musculoskeletal conditions 2008-09, shows that in 2008-09, spending on these diseases totalled $5,690 million, accounting for 9% of total health-care spending.
'Osteoarthritis accounted for 29%-or $1,637 million-of spending on arthritis and other musculoskeletal conditions,' said AIHW spokesperson Louise York.
This was followed by back problems (21% or $1,177 million), rheumatoid arthritis (6% or $355 million) and osteoporosis (5% or $306 million).
More than half of spending on arthritis and other musculoskeletal conditions was on hospital admitted patient services ($3,091 million), followed by 30% on out-of-hospital medical expenses ($1,677 million) and 16% on prescription pharmaceuticals ($922 million).
'Patterns of spending across health-care sectors varied significantly among different musculoskeletal conditions,' Ms York said.
'For example, most spending for rheumatoid arthritis and osteoporosis was on pharmaceuticals (77% and 63% respectively), while for osteoarthritis, most was spent on admitted patient hospital services (77%) such as joint replacement surgery and arthroscopies.'
Overall spending on these conditions also varied by age, and was highest for people in the 65-74 age group ($1,245 million).
'However, spending per person was actually highest for people aged 75-84, at an average of $1,007 per person.'
Overall, spending was higher for females than males, averaging $301 for females compared with $229 for males.
From 2000-01 to 2008-09, total health system spending on arthritis and other musculoskeletal conditions rose by 67%. This compares with a total rise of 52% for spending on all chronic diseases. Over the same period, the proportion of total expenditure on diseases spent on musculoskeletal conditions remained stable, at around 9%.
'About 6.1 million people (28% of the total population) were affected by musculoskeletal conditions in 2011-12,' Ms York said.
The AIHW is a major national agency set up by the Australian Government to provide reliable, regular and relevant information and statistics on Australia's health and welfare.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.